Literature DB >> 10381821

Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle.

A Moriyama1, K Shimoya, I Ogata, T Kimura, T Nakamura, H Wada, K Ohashi, C Azuma, F Saji, Y Murata.   

Abstract

Secretory leukocyte protease inhibitor (SLPI) is a potent inhibitor of human leukocyte elastase. SLPI transcripts in the cervical tissue were detected during the menstrual cycle by reverse transcription-polymerase chain reaction (RT-PCR). Western blot analysis revealed that the intensity of SLPI protein in cervical tissue in the ovulatory phase was stronger than in other phases. Immunohistochemistry using an anti-SLPI polyclonal antibody revealed positive staining in the epithelial cells of the endocervix. Western blot analysis also revealed that SLPI protein was present in the cervical mucus. Again the intensity of SLPI protein in the ovulatory phase was stronger than that in the follicular phase. The SLPI concentrations and SLPI/elastase ratios in the cervical mucus of women in the ovulatory phase were significantly higher than in the follicular and luteal phases. The SLPI and elastase concentrations in the cervical mucus were positively correlated. No significant difference was found in the SLPI serum concentrations of women during the menstrual cycle. These results suggest that production of SLPI from cervical epithelial cells during the ovulatory phase may be important for protection from the effects of elastase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381821     DOI: 10.1093/molehr/5.7.656

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  29 in total

1.  The innate immune system: gatekeeper to the female reproductive tract.

Authors:  Charles R Wira; John V Fahey
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

2.  Innate immune mediator profiles and their regulation in a novel polarized immortalized epithelial cell model derived from human endocervix.

Authors:  Lyndsey R Buckner; Danny J Schust; Jian Ding; Takeshi Nagamatsu; Wandy Beatty; Theresa L Chang; Sheila J Greene; Maria E Lewis; Bernardo Ruiz; Stacey L Holman; Rae Ann Spagnuolo; Richard B Pyles; Alison J Quayle
Journal:  J Reprod Immunol       Date:  2011-09-22       Impact factor: 4.054

3.  Secretory leukocyte protease inhibitor binds to Neisseria gonorrhoeae outer membrane opacity protein and is bactericidal.

Authors:  Morris D Cooper; Melissa H Roberts; Ona L Barauskas; Gary A Jarvis
Journal:  Am J Reprod Immunol       Date:  2012-04-26       Impact factor: 3.886

4.  HIV is inactivated after transepithelial migration via adult oral epithelial cells but not fetal epithelial cells.

Authors:  Sharof M Tugizov; Rossana Herrera; Piri Veluppillai; Deborah Greenspan; Vanessa Soros; Warner C Greene; Jay A Levy; Joel M Palefsky
Journal:  Virology       Date:  2010-11-05       Impact factor: 3.616

5.  Conditionally reprogrammed macaque endocervical cells retain steroid receptor expression and produce mucus.

Authors:  Leo Han; Walker Andrews; Karsten Wong; Jeffrey T Jensen
Journal:  Biol Reprod       Date:  2020-05-26       Impact factor: 4.285

6.  Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.

Authors:  Andrea L Radtke; Alison J Quayle; Melissa M Herbst-Kralovetz
Journal:  Biol Reprod       Date:  2012-12-06       Impact factor: 4.285

7.  Safety analysis of the diaphragm in combination with lubricant or acidifying microbicide gels: effects on markers of inflammation and innate immunity in cervicovaginal fluid.

Authors:  Deborah J Anderson; D'Nyce L Williams; Susan A Ballagh; Kurt Barnhart; Mitchell D Creinin; Daniel R Newman; Frederick P Bowman; Joseph A Politch; Ann C Duerr; Denise J Jamieson
Journal:  Am J Reprod Immunol       Date:  2009-02       Impact factor: 3.886

Review 8.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

9.  Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model.

Authors:  Chris L McGowin; Andrea L Radtke; Kyle Abraham; David H Martin; Melissa Herbst-Kralovetz
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

10.  Innate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretions.

Authors:  Mickey V Patel; Mimi Ghosh; John V Fahey; Christina Ochsenbauer; Richard M Rossoll; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2014-05-08       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.